
HanchorBio and WuXi Biologics Form Fusion Protein Pipeline Partnership
The collaboration is designed to accelerate clinical translation and support scalable global development and manufacturing of HanchorBio's fusion protein portfolio derived from its Fc-Based Designer Biologics (FBDB) platform.The post HanchorBio and WuXi Biologics Form Fusion Protein Pipeline Partnership appeared first on GEN - Genetic Engineering and Biotechnology News.









